Share：
Share this content in WeChat
X
[Chinese][PDF]98978
• Clinical Article •
Using multiparametric MRI to differentiate uterine leiomyosarcoma from atypical leiomyoma
BI Qiu  LÜ Fa-jin  XIAO Zhi-bo  ZOU Chun-xia  SHEN Yi-qing  LIU Xiao-shuang 

DOI:10.12015/issn.1674-8034.2018.02.006.


[Abstract] Objective: To explore the diagnostic value of clinical parameters and qualitative and quantitative magnetic resonance imaging (MRI) features in distinguishing uterine leiomyosarcoma (LMS) from atypical leiomyoma (ALM).Materials and Methods: From June 2011 to December 2016, clinical data of 19 LMSs and 88 ALMs confirmed by pathology was collected in our hospital. Twelve LMSs and 79 ALMs underwent MRI scan before surgery and met the conditions. Analyzing and comparing the differences in MRI qualitative features, diffusion weighted imaging (DWI), and dynamic contrast-enhanced parameters between LMS and ALM.Results: There were significant differences between LMS and ALM in the following qualitative MRI parameters: LMS was mainly located in the uterine cavity with an ill-defined margin, showed heterogeneous signal on T2WI and hyperintensity on DWI, no enhancement region was in the center of the tumor on contrast-enhanced MRI (P<0.05). For quantitative MRI parameters, mean apparent diffusion coefficient (mADC) values, early enhancement ratio (EER), maximum contrast enhancement ratio (MCER) of the solid component of LMS could help to distinguish from ALM (P< 0.05). According to receiver operating characteristic (ROC) curves, when the cut-off values of mADC was 1.09×10-3 mm2/s, the sensitivity and specificity were 97.5% and 75.0%.Conclusions: It was valuable to use multiparametric MRI to differentiate LMS from ALM.
[Keywords] Leiomyosarcoma；Hysteromyoma；Magnetic resonance imaging

BI Qiu Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

LÜ Fa-jin* Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

XIAO Zhi-bo Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

ZOU Chun-xia Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

SHEN Yi-qing Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

LIU Xiao-shuang Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

*Correspondence to: Lü FJ, E-mail: fajinlv@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Prior Clinical Specialization Building Project No.2013544
Received  2017-11-16
Accepted  2018-01-05
DOI: 10.12015/issn.1674-8034.2018.02.006
DOI:10.12015/issn.1674-8034.2018.02.006.

[1]
Piura B, Rabinovich A, Yanai-Inbar I, et al. Uterine sarcoma in the south of Israel: study of 36 cases. J Surg Oncol, 1997, 64(1): 55-62.
[2]
Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol, 2015, 21(1): 4-9.
[3]
Gadducci A, Cosio S, Romanini A, et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol, 2008, 65(2): 129-142.
[4]
Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health, 2014(6): 95-114.
[5]
Zhao WC, Bi FF, Li D, et al. Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10248 cases. Onco Targets Ther, 2015(8): 2943-2948.
[6]
Lin G, Yang LY, Huang YT, et al. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma/smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging, 2016, 43(2): 333-342.
[7]
Barral M, Placé V, Dautry R, et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol (NY), 2017, 42(6): 1762-1772.
[8]
Xue KK, Cheng JL, Bai J, et al. Value of DWI and dynamic contrast-enhanced MRI in differentially diagnosing uterine sarcomas and degenrated leiomyomas. Chin L Med Imaging Technol, 2016, 32(2): 274-278.薛康康，程敬亮，白洁，等. DWI及动态增强MRI鉴别诊断子宫肉瘤与变性子宫肌瘤的价值．中国医学影像技术, 2016, 32(2): 274-278.
[9]
Goto A, Takeuchi S, Sugimura K, et al. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer, 2002, 12(4): 354-361.
[10]
Skorstad M, Kent A, Lieng M. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study. Acta Obstet Gynecol Scand, 2016, 95(11): 1228-1234.
[11]
Lakhman Y, Veeraraghavan H, Chaim J, et al. Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol, 2017, 27(7): 2903-2915.
[12]
Feng W, Malpica A, Robboy SJ, et al. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Int J Gynecol Pathol, 2013, 32(3): 299-306.
[13]
Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol, 2011, 25(6): 681-689.
[14]
Zhang GF, Zhang H, Tian XM, et al. Magnetic resonance and diffusion-weighted imaging in categorization of uterine sarcomas: correlation with pathological findings. Clin Imaging, 2014, 38(6): 836-844.
[15]
Poncelet C, Fauvet R, Feldmann G, et al. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. J Surg Oncol, 2004, 86(2): 84-90.

PREV Clinical value of Gd-EOB-DTPA-enhanced MRI for diagnosis of focal hepatic lesions
NEXT Assessment of diffusion kurtosis imaging in lumbar intervertebral disc degeneration
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn